NurExone: Loading Exosomes with Therapeutic MoleculesNurExone reported today results of a pre-clinical loading efficiency study that was completed by the Company showing that its innovative and proprietary loading technology has the potential to serve as an efficient process for loading of therapeutic molecular cargo into exosomes. In exosome-based therapies, loaded exosomes are biologically guided to target inflamed tissues to "dock" and unload their therapeutic cargo, creating a healing environment.
Read more here: [url=https://www.newsfilecorp.com/release/146207/NurExone-Biologic-Successfully-Demonstrates-its-PatentPending-Platform-Technology-for-Loading-Exosomes-with-Therapeutic-Moleculeshttps://www.newsfilecorp.com/release/146207/NurExone-Biologic-Successfully-Demonstrates-its-PatentPending-Platform-Technology-for-Loading-Exosomes-with-Therapeutic-Molecules]https://www.newsfilecorp.com/release/146207/NurExone-Biologic-Successfully-Demonstrates-its-PatentPending-Platform-Technology-for-Loading-Exosomes-with-Therapeutic-Molecules[/url]